Northwestern Mutual Wealth Management’s Olema Pharmaceuticals OLMA Stock Holding History

Northwestern Mutual Wealth Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.88K	Buy	+550	New	+$7.37K	﹤0.01%	3264

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Northwestern Mutual Wealth Management's OLMA Position: Q2 2026 in Review

Northwestern Mutual Wealth Management opened a new position in Olema Pharmaceuticals (OLMA) in Q2 2026: 550 shares worth $6.88K. The stake represents ﹤0.01% of the portfolio and ranks #3264 among its holdings.

184 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Northwestern Mutual Wealth Management held 550 shares of Olema Pharmaceuticals worth $6.88K as of Q2 2026.
Olema Pharmaceuticals was a new Northwestern Mutual Wealth Management position in Q2 2026.
Olema Pharmaceuticals made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #3264 holding.
184 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.